Related Experiment Video
Updated: Jan 13, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Chronic Urticaria Part II: Clinical management and therapeutics.
Peyton V Warp1, Ana Maria Giménez-Arnau2, Brian S Kim3
1Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
Chronic urticaria (CU), a mast-cell driven condition, requires timely treatment for symptom elimination. This review covers antihistamines, immunosuppressants, biologics, and novel therapies for effective chronic urticaria management.
Area of Science:
- Immunology
- Dermatology
Background:
- Chronic urticaria (CU) is a mast-cell mediated condition causing recurrent wheals and angioedema lasting over six weeks.
- Effective management of CU is crucial for disease control and improving patient quality of life.
Purpose of the Study:
- To provide a comprehensive review of complex chronic urticaria management.
- To discuss current and emerging therapeutic strategies for CU.
Main Methods:
- Review of current literature on chronic urticaria treatments.
- Analysis of the roles of antihistamines, immunosuppressants, and biologics.
- Exploration of novel therapeutic approaches and ongoing investigations.
Main Results:
- Antihistamines, immunosuppressants, and biologics are key components in CU management.
- The therapeutic landscape for CU is dynamic, with new agents under investigation.
- Focus on achieving symptom elimination with safe, effective, and minimally dosed therapies.
Conclusions:
- Optimal management of chronic urticaria involves a multi-faceted approach.
- Evolving treatment options, including biologics and small molecules, offer promise for difficult-to-treat CU.
- Continued research into mast cell-directed therapies is essential for advancing CU care.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Myocarditis III: Medical Management
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Nephrotic Syndrome III : Nursing Management
Atherosclerosis III: Management

